Grantham, Mayo, Van Otterloo & Co (GMO)’s Escalade ESCA Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ESCA Stock Details ESCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,300	Closed	-$207K	–	826
2020 Q3	$207K	Sell	11,300 -3,249	-22%	-$54.7K	﹤0.01%	729
2020 Q2	$203K	Sell	14,549 -2,000	-12%	-$18.5K	﹤0.01%	709
2020 Q1	$98K	Sell	16,549 -2,569	-13%	-$21.1K	﹤0.01%	728
2019 Q4	$188K	Hold	19,118	–	–	﹤0.01%	656
2019 Q3	$208K	Sell	19,118 -300	-2%	-$3.28K	﹤0.01%	696
2019 Q2	$223K	Hold	19,418	–	–	﹤0.01%	673
2019 Q1	$217K	Buy	+19,418	New	+$229K	﹤0.01%	674

Other funds holding ESCA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NSIM

North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PBO

Peoples Bank (Ohio) Marietta, Ohio $195M AUM 28.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ESCA Position: Q4 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Escalade (ESCA) in Q4 2020, closing a stake of 11,300 shares — an estimated $207K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ESCA in Q1 2019 and held it in 7 quarters. The position peaked at $223K in Q2 2019. 65 funds tracked by Wall St. Rank hold ESCA as of Q4 2020.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Escalade position as of Q4 2020 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 11,300 Escalade shares in Q4 2020, an estimated $207K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Escalade in Q1 2019 and held it in 7 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Escalade position peaked at $223K in Q2 2019.
65 funds tracked by Wall St. Rank held Escalade as of Q4 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2020, filed 12 Feb 2021.